Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Tumours × Irinotecan × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 30 Solid Tumors 7 Solid Tumor 6 Unspecified Childhood Solid Tumor, Protocol Specific 5 Advanced Solid Tumor 5 Advanced Solid Tumors 4 Pediatric Solid Tumor 2 Stomach Neoplasms 1 Solid Tumor Malignancy 1 Sarcoma 1 Relapsed Solid Tumors 1 Refractory Solid Tumors in Children 1 Refractory Solid Tumors 1 Pediatric Solid Tumors 1 P1b: Advanced Solid Tumors 1 Neuroendocrine Tumors 1 Neoplasms 1 Mesothelioma 1 MSI-H Advanced Colorectal Cancer 1 Locally Advanced (Unresectable) or Metastatic Solid Tumors 1 Glioblastoma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Childhood Solid Tumors 1 Carcinoma, Ovarian Epithelial 1 Advanced Solid Tumours 1

Interventions

adavosertib 4 Paclitaxel 3 pembrolizumab 2 olaparib 2 durvalumab 2 ceralasertib 2 Fluorouracil 2 Carboplatin 2 sintilimab 1 factor IX, factor VII, factor X, prothrombin drug combination 1 drug XX Z 1 danvatirsen 1 capivasertib 1 Rifampin 1 Pantoprazole 1 Omeprazole 1 Leucovorin 1 Itraconazole 1 Irinotecan 1 Injections 1 Gemcitabine 1 Doxorubicin 1 Cisplatin 1 AZD0156 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02588105 2022-09-19

AToM

AstraZeneca

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon ⚡